Moreover, neuroblastoma cells were exposed to the EGFR irreversible inhibitor canertinib (CI‐1033) after analyzing IC50 concentrations (Table S4) and cell viability was inhibited at low micromolar concentrations. The gene discussed is EGFR; the disease is neuroblastoma.